The Role of Systemic Inflammatory Indices in Predicting Cardiovascular Involvement in Children with Duchenne Muscular

Ecem İpek Altınok1, Taner Kasar2

  • 1Department of Pediatrics, Faculty of Medicine, Ordu University, 52200 Ordu, Türkiye.

PubMed

Insights

In Duchenne Muscular Dystrophy (DMD), inflammatory markers like the platelet-to-lymphocyte ratio (PLR) may indicate cardiac stress. Further research is needed to confirm PLR

Area of Science:

  • Biomedical research
  • Cardiovascular medicine
  • Neuromuscular disorders

Background:

  • Duchenne Muscular Dystrophy (DMD) is a severe X-linked neuromuscular disorder.
  • Cardiovascular complications are the leading cause of mortality in DMD patients.
  • Systemic inflammatory markers are being investigated as predictors of cardiac involvement.

Purpose of the Study:

  • To evaluate the prognostic value of various inflammatory markers in children with DMD.
  • To explore the association between these inflammatory indices and cardiac findings in DMD.

Main Methods:

  • Retrospective study of 25 male DMD patients and 25 healthy controls.
  • Analysis of demographic, clinical, hematologic, and inflammatory data.
  • Assessment of cardiovascular involvement via ECG and echocardiography; correlation analysis performed.

Main Results:

  • Most inflammatory indices (NLR, MLR, SIRI, SII, PIV) did not significantly correlate with cardiac involvement.
  • Platelet-to-lymphocyte ratio (PLR) showed a significant positive correlation with Pro-BNP levels (r = 0.86, p < 0.05).
  • ECG abnormalities (24%) and echocardiographic abnormalities (16%) were observed in DMD patients.

Conclusions:

  • Systemic inflammatory indices have limited diagnostic utility for predicting cardiovascular complications in DMD.
  • PLR may be a potential indicator of subclinical cardiac stress in DMD, correlating with Pro-BNP.
  • Larger prospective studies are required to validate the clinical significance of PLR in DMD cardiovascular assessment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
492
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
267
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
800